What is DMAA's relative strength rating?

DMAA ranks at the 49th percentile over 1 month, 47th percentile over 3 months, 54th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is DMAA in?

DMAA is classified under the Financials sector within the Trading industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Financials is currently ranked 4 of 11 sectors by relative strength.

Is DMAA in a leading sector?

Yes — Financials ranks at the 73th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). DMAA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is DMAA?

DMAA currently shows a 20-day average daily range (ADR%) of 0.2%, a 90-day beta versus the S&P 500 of 0.01. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does DMAA have a seasonal pattern?

TickerStance computes DMAA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what DMAA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did DMAA last report earnings?

DMAA most recently filed a 10-Q covering — with the SEC on 2026-08-14. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Drugs Made In America Acquisition Corp. Ordinary Shares...

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) has a 3-month relative strength percentile of 47 within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Financials, ranked 4 of 11. Average daily range 0.2%, relative volume 1.15×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month47pctile

6 month54pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile 51

!ADR%0.2%!A/DE!RVOL1.15×!$ Vol$378K

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2025

Best monthJul on averageavg +0.63% · 100% win · n 2

Worst monthAug on averageavg -0.16% · 0% win · n 1

DMAA monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	DMAA Jan avg: 0.54% median: 0.54% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAA Feb avg: 0.19% median: 0.19% win: 100% σ: 0.13% n: 2 2025-02-26 → 2026-07-31	DMAA Mar avg: 0.35% median: 0.35% win: 100% σ: 0.22% n: 2 2025-02-26 → 2026-07-31	DMAA Apr avg: 0.59% median: 0.59% win: 100% σ: 0.16% n: 2 2025-02-26 → 2026-07-31	DMAA May avg: 0.58% median: 0.58% win: 100% σ: 0.26% n: 2 2025-02-26 → 2026-07-31	DMAA Jun avg: 0.53% median: 0.53% win: 100% σ: 0.22% n: 2 2025-02-26 → 2026-07-31	DMAA Jul avg: 0.63% median: 0.63% win: 100% σ: 0.09% n: 2 2025-02-26 → 2026-07-31	DMAA Aug avg: -0.16% median: -0.16% win: 0% σ: 0.00% n: 1 2025-02-26 → 2026-07-31 (current)	DMAA Sep avg: 0.16% median: 0.16% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAA Oct avg: 0.39% median: 0.39% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAA Nov avg: 0.19% median: 0.19% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31	DMAA Dec avg: 0.43% median: 0.43% win: 100% σ: 0.00% n: 1 2025-02-26 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

49

3m

47

6m

54

1y

—

LDR

—

StageWeinstein stage analysis

Stage 2 · Uptrend✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · DMAA

Does the business back the chart?

SEC EDGAR · last filing 10-Q · — · period end —

—

Fundamentals Growth Rank

How does growth rank vs. the universe?

Structurally fundamentals-ineligible: SIC 6770 blank check issuer

View fundamental leadership map

Earnings

Is earnings accelerating?

Diluted EPS, last 8 quarters. Positive EPS uses YoY change.

—

Latest Q EPS—YoY —

Revenue

Is revenue confirming?

YoY sales growth, last 8 quarters. Sales must back the earnings story.

—

Latest Q YoY—

Quality

Are margins expanding?

Operating margin unavailable

No comparable operating-income series in SEC facts.

TTM op margin-

Float

Evidence · 2 of 3

Sector context

Financials · 73th pctile in sector

Top peers · Financials

Who else is leading?

TOP
99RS 3m
APPS
99RS 3m
LIFE
98RS 3m
DMAA
47RS 3m · you

Sector vs market

Financials · 4 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Trading

Same industry, closest relative strength

4 peers · by RS6M

SIMASIM Acquisition Corp. I Class A Ordinary Shares54 DHCNLDiversified Healthcare Trust 6.25% Senior Notes Due 204655 HRHealthcare Realty Trust Incorporated54 LANDOGladstone Land Corporation 6.00% Series B Cumulative Redeemable Preferred Stock54

Public attention · DMAA

Is the crowd watching?

29/ 100 · vs its own 90-day norm▼ 41 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

Reference

Company snapshot

SectorFinancials

IndustryTrading

SIC6770

Float21.0Mshares

Shares out24.3Mshares

Market cap$260.7MMicro Cap

FAQ

Frequently asked questions

What is DMAA's relative strength rating?: DMAA ranks at the 49th percentile over 1 month, 47th percentile over 3 months, 54th percentile over 6 months against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is DMAA in?: DMAA is classified under the Financials sector within the Trading industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Financials is currently ranked 4 of 11 sectors by relative strength.
Is DMAA in a leading sector?: Yes — Financials ranks at the 73th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). DMAA benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is DMAA?: DMAA currently shows a 20-day average daily range (ADR%) of 0.2%, a 90-day beta versus the S&P 500 of 0.01. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does DMAA have a seasonal pattern?: TickerStance computes DMAA's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what DMAA has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Sector context

Who else is leading?

Financials · 4 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Share count: tailwind or headwind?

§ Seasonality

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) — Stance & relative strength

DMAA is not confirmed as a leader. 47 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Is earnings accelerating?

Is revenue confirming?

Are margins expanding?

Sector context

Who else is leading?

Financials · 4 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Share count: tailwind or headwind?